Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases—development and validation of the LabBM score

BACKGROUND: We aimed to investigate the potential of standard hematologic and serum biochemical parameters to provide an independent and substantial contribution to the prediction of survival in patients with newly diagnosed brain metastases (BM). METHODS: Hemoglobin, white blood cell count, platele...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Berghoff, Anna S, Wolpert, Fabian, Holland-Letz, Tim, Koller, Romina, Widhalm, Georg, Gatterbauer, Brigitte, Dieckmann, Karin, Birner, Peter, Bartsch, Rupert, Zielinski, Christoph C, Weller, Michael, Preusser, Matthias
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Clinical Investigations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5570252/
https://ncbi.nlm.nih.gov/pubmed/28096493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now290
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak